»çÀÌÅäÄ«ÀÎ ½ÃÀå : À¯Çüº°, Ä¡·á ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Cytokine Market, By Type, By Therapeutic Application, By End User, By Geography
»óǰÄÚµå
:
1673038
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀåÀº 2025³â¿¡ 988¾ï 4,000¸¸ ´Þ·¯, 2032³â¿¡´Â 1,785¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 8.8%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í ¹üÀ§
º¸°í¼ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ
2024³â
2025³â ½ÃÀå ±Ô¸ð
988¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR
8.80%
2032³â °¡Ä¡ ¿¹Ãø
1,785¾ï ´Þ·¯
±×¸². 2025³â Áö¿ªº° »çÀÌÅäÄ«ÀÎ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°
»çÀÌÅäÄ«ÀÎÀº ¸é¿ª¹ÝÀÀ°ú ¿°Áõ¹ÝÀÀÀ» Á¦¾îÇϰí Á¶ÀýÇÏ´Â µ¥ Áß¿äÇÑ ¼¼Æ÷ ½ÅÈ£Àü´Þ ´Ü¹éÁúÀÔ´Ï´Ù. »çÀÌÅäÄ«ÀÎÀº ¸é¿ª¼¼Æ÷ °£ÀÇ °¡±³¿ªÇÒÀ» Çϸç, ¸é¿ª¹ÝÀÀÀÇ ÀϺηΠ¸é¿ª°ú ¿°ÁõÀ» ¸Å°³Çϰųª Á¶ÀýÇÕ´Ï´Ù. ¸¸¼º ¿°Áõ¼º Áúȯ, ¾Ï, °¨¿°¼º Áúȯ Áõ°¡¿Í ÇÔ²² Áø´Ü ¸ñÀûÀÇ »çÀÌÅäÄ«ÀÎ ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ DNA ±â¼úÀÇ ¹ßÀüÀ¸·Î ´Ù¾çÇÑ À¯ÇüÀÇ »çÀÌÅäÄ«ÀÎÀ» ´ë·® »ý»êÇÒ ¼ö ÀÖ°Ô µÇ¾î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª »çÀÌÅäÄ«ÀÎ ¿¬±¸¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå È®´ë°¡ ¾î´À Á¤µµ ¾ïÁ¦µÉ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ
¸¸¼º Áúȯ ¹× »ý¸íÀ» À§ÇùÇÏ´Â Áúº´ÀÇ ¹ßº´·ü Áõ°¡´Â »çÀÌÅäÄ«ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â Àü ¼¼°è ¾Ï°ú °¨¿°¼º Áúȯ Áõ°¡¸¦ µé ¼ö ÀÖ½À´Ï´Ù. Àü ¼¼°è ¾Ï ȯÀÚ ¼ö´Â 1,930¸¸ ¸í¿¡ ´ÞÇϸç, 2020³â¿¡´Â 1,000¸¸ ¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¶Âù°¡Áö·Î Äڷγª19, °áÇÙ°ú °°Àº °¨¿°¼º ÁúȯÀº »çÀÌÅäÄ«ÀÎ ÇÁ·ÎÆÄÀϸµÀ» Æ÷ÇÔÇÑ »õ·Î¿î Áø´Ü ¹× Ä¡·á Á¢±Ù¹ýÀÇ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »çÀÌÅäÄ«ÀÎ ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ¹× ¹Î°£ ±â°üÀÇ ÀÚ±Ý Áö¿øÀ» ´Ã¸®±â À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª »çÀÌÅäÄ«ÀÎ »ý»ê ±â¼úÀÇ ³ôÀº »ý»ê ºñ¿ë°ú ±â¼úÀû ÇѰè·Î ÀÎÇØ ½ÃÀå ÀáÀç·ÂÀÌ °è¼Ó ÀúÇØµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »çÀÌÅäÄ«ÀÎÀÇ ÂªÀº À¯Åë±âÇѰú ³·Àº ¾ÈÁ¤¼ºÀº º¸´Ù ±¤¹üÀ§ÇÑ »ó¾÷È¿¡ ´ëÇÑ µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
¼¼°èÀÇ »çÀÌÅäÄ«ÀÎ(Cytokine) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ¿¹ÃøÇÑ º¸°í¼ÀÔ´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀ» ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott, AB Sciex, Agilent Technologies Inc, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd. Quest Diagnostics Inc., Danaher, DiaSorin S.p.A., Immunodiagnostic Systems, Fujirebio, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¿µÇ⠺м®
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦Ç° ¹ß¸Å/½ÂÀÎ
PEST ºÐ¼®
PORTER ºÐ¼®
ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
Á¦4Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, À¯Çüº°, 2020³â-2032³â(10¾ï ´Þ·¯)
Tumor Necrosis Factor-TNF
Interleukins-II
Interferons-IFN
Epidermal Growth Factor-EGF
±âŸ
Á¦5Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, Ä¡·á ¿ëµµº°, 2020³â-2032³â(10¾ï ´Þ·¯)
¾Ï
õ½Ä
°üÀý¿°
Ç÷¾×ÇÐ
±âŸ
Á¦6Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â(10¾ï ´Þ·¯)
Á¦7Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, Áö¿ªº°, 2020³â-2032³â, ±Ý¾×(10¾ï ´Þ·¯)
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
秵¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï ±¸µµ
Abbott
AB Sciex
Agilent Technologies Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
DiaSorin S.p.A.
F.Hoffmann-La Roche Ltd.
Quest Diagnostics Inc
Danaher
DiaSorin S.p.A
Immunodiagnostic Systems
Fujirebio, Inc.
Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×
±âȸ
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
Coherent Opportunity Map
Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
Âü°í ¹®Çå
Á¶»ç ¹æ¹ý
ÃâÆÇ»ç¿¡ ´ëÇØ
LSH
¿µ¹® ¸ñÂ÷
Global Cytokine Market is estimated to be valued at USD 98.84 Bn in 2025 and is expected to reach USD 178.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 98.84 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
8.80%
2032 Value Projection:
USD 178.50 Bn
Figure. Cytokine Market Share (%), By Region 2025
Cytokines are cell-signalling proteins that are crucial for controlling and regulating immune responses and inflammatory reactions. They act as the bridge intermediaries between immune cells and mediate or regulate immunity and inflammation as part of immune response. With the increasing prevalence of chronic inflammatory diseases, cancer, and infectious diseases, the demand for cytokine assays for diagnostic purposes has been growing significantly. Advancements in recombinant DNA technology have enabled mass production of different types of cytokines, thus aiding market growth. However, high costs associated with cytokine research may restrain market expansion to some extent over the forecast period.
Market Dynamics:
Increasing incidence of chronic and life-threatening diseases is a key factor driving the cytokine market growth. Some of the major market drivers include rising cases of cancers and infectious diseases globally. , the global cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Similarly, infectious diseases like COVID-19, tuberculosis, etc. have surged the need for new diagnostic and therapeutic approaches including cytokine profiling. Further, initiatives by governments and private organizations to increase funding for cytokine research present lucrative opportunities for market players. However, high production costs and technical limitations of cytokine production techniques continue to hamper market potential. Short shelf-life and poor stability of cytokines also challenge wider commercialization.
Key Features of the Study:
This report provides in-depth analysis of the global cytokine market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cytokine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, DiaSorin S.p.A, Immunodiagnostic Systems, Fujirebio, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cytokine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cytokine market
Market Segmentation
Type Insights (Revenue, USD Bn, 2020 - 2032)
Tumor Necrosis Factor-TNF
Interleukins-II
Interferons-IFN
Epidermal Growth Factor-EGF
Others
Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
Cancer
Asthma
Arthritis
Hematology
Others
End User Insights (Revenue, USD Bn, 2020 - 2032)
Hospitals
Research laboratories
Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Abbott
AB Sciex
Agilent Technologies Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
DiaSorin S.p.A.
Hoffmann-La Roche Ltd.
Quest Diagnostics Inc
Danaher
DiaSorin S.p.A
Immunodiagnostic Systems
Fujirebio, Inc.
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Cytokine Market, By Type
Cytokine Market, By Therapeutic Application
Cytokine Market, By End User
Cytokine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Cytokine Market, By Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Tumor Necrosis Factor-TNF
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Interleukins-II
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Interferons-IFN
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Epidermal Growth Factor-EGF
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Cytokine Market, By Therapeutic Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Cytokine Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Cytokine Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Latin America
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country/Region 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Abbott
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AB Sciex
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Agilent Technologies Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
bioMerieux SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bio-Rad Laboratories Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
DiaSorin S.p.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
F.Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Quest Diagnostics Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Danaher
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
DiaSorin S.p.A
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Immunodiagnostic Systems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fujirebio, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us
°ü·ÃÀÚ·á